Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Invest Dermatol ; 135(11): 2611-2622, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26134949

RESUMEN

The role of reactive oxygen species (ROS) in the regulation of hair follicle (HF) cycle and skin homeostasis is poorly characterized. ROS have been traditionally linked to human disease and aging, but recent findings suggest that they can also have beneficial physiological functions in vivo in mammals. To test this hypothesis, we transiently switched on in situ ROS production in mouse skin. This process activated cell proliferation in the tissue and, interestingly, in the bulge region of the HF, a major reservoir of epidermal stem cells, promoting hair growth, as well as stimulating tissue repair after severe burn injury. We further show that these effects were associated with a transient Src kinase phosphorylation at Tyr416 and with a strong transcriptional activation of the prolactin family 2 subfamily c of growth factors. Our results point to potentially relevant modes of skin homeostasis regulation and demonstrate that a local and transient ROS production can regulate stem cell and tissue function in the whole organism.


Asunto(s)
Quemaduras/patología , Proliferación Celular/fisiología , Fototerapia , Especies Reactivas de Oxígeno/metabolismo , Nicho de Células Madre/fisiología , Cicatrización de Heridas/fisiología , Animales , Quemaduras/metabolismo , Células Cultivadas , Modelos Animales de Enfermedad , Células Epiteliales/metabolismo , Femenino , Cabello/crecimiento & desarrollo , Folículo Piloso/metabolismo , Humanos , Inmunohistoquímica , Queratinocitos/metabolismo , Ratones , Ratones Endogámicos C57BL , Distribución Aleatoria
2.
J Burn Care Res ; 36(1): 7-13, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25167374

RESUMEN

Emerging bacterial resistance renders many antibiotics ineffective, making alternative strategies of wound disinfection important. Here the authors report on a new, physical burn wound disinfection method: pulsed electric fields (PEFs). High voltage, short PEFs create nonthermal, permanent damage to cell membranes, possibly by irreversible electroporation. In medicine, PEF technology has recently been used for nonthermal ablation of solid tumors. The authors have expanded the spectrum of PEF applications in medicine to burn wound disinfection. A third-degree burn was induced on the dorsal skin of C57BL/6 mice. Immediately after the injury, the burn wound was infected with Acinetobacter baumannii expressing the luxCDABE operon. Thirty minutes after infection, the infected areas were treated with 80 pulses delivered at 500 V/mm, 70 µs, 1 Hz. The authors used bioluminescence to quantify bacteria on skin. Three animals were used for each experimental condition. PEFs were effective in the disinfection of infected burned murine skin. The bacterial load reduction correlated with the number of delivered pulses. Forty pulses of 500 V/mm led to a 2.04 ± 0.29 Log10 reduction in bacterial load; 80 pulses led to the immediate 5.53 ± 0.30 Log10 reduction. Three hours after PEF, the bacterial reduction of the skin treated with 500 V/mm, 80 pulses was 4.91 ± 0.71 Log10. The authors introduce a new method of wound disinfection using high voltage, short PEFs. They believe that PEF technology may represent an important alternative to antibiotics in addressing bacterial contamination of wounds, particularly those contaminated with multidrug-resistant bacteria.


Asunto(s)
Infecciones por Acinetobacter/terapia , Acinetobacter baumannii , Quemaduras/terapia , Desinfección/métodos , Terapia por Estimulación Eléctrica/métodos , Infección de Heridas/terapia , Infecciones por Acinetobacter/etiología , Infecciones por Acinetobacter/patología , Animales , Carga Bacteriana , Quemaduras/microbiología , Modelos Animales de Enfermedad , Femenino , Ratones , Ratones Endogámicos C57BL , Infección de Heridas/microbiología
3.
Autoimmunity ; 48(1): 46-56, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25046647

RESUMEN

Oxidative stress (OS) is important in the pathogenesis of autoimmune diseases such as rheumatoid arthritis (RA) and its experimental model--adjuvant arthritis (AA). Antioxidants are scarcely studied in autoimmunity, and future analyses are needed to assess its effects in ameliorating these diseases. Although there are studies about antioxidants effects on the course of RA, their role in combination therapy has not yet been studied in detail, especially on extra-articular manifestations of AA. During the 28-d administration of pinosylvin (PIN) in monotherapy and in combination with methotrexate (MTX) to AA rats, we evaluated the impact of the treatment on selected parameters. The experiment included: healthy controls, untreated AA, AA administered 50 mg/kg b.w. of PIN daily p.o., AA administered 0.4 mg/kg b.w. of MTX twice weekly p.o. and AA treated with a combination of PIN+MTX. AA was monitored using: hind paw volume, C-reactive protein, monocyte chemotactic protein-1 (MCP-1), thiobarbituric acid reactive substances (TBARS) and F2-isoprostanes in plasma, γ-glutamyltransferase activity in spleen, activity of lipoxygenase (LOX) in lung, heme oxygenase-1 (HO-1) and nuclear factor kappa B (NF-κB) in liver and lung. PIN monotherapy significantly improved the activation of NF-κB in liver and lung, HO-1 expression and activity of LOX in the lung, MCP-1 levels in plasma (on 14th d) and plasmatic levels of F2-isoprostanes. An important contribution of PIN to MTX effect was the reduction of OS (an increase of HO-1 expression in lung and reduction of plasmatic TBARS) and decrease of LOX activity in the lung.


Asunto(s)
Antirreumáticos/farmacología , Artritis Experimental/tratamiento farmacológico , Artritis Experimental/metabolismo , Metotrexato/farmacología , Estilbenos/farmacología , Animales , Artritis Experimental/patología , Biomarcadores/metabolismo , Proteína C-Reactiva/metabolismo , Quimiocina CCL2/sangre , Sinergismo Farmacológico , Quimioterapia Combinada , F2-Isoprostanos/sangre , Hemo-Oxigenasa 1/metabolismo , Miembro Posterior , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Inflamación/patología , Lipooxigenasa/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Masculino , FN-kappa B/metabolismo , Estrés Oxidativo , Ratas , Ratas Endogámicas Lew , Bazo/efectos de los fármacos , Bazo/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , gamma-Glutamiltransferasa/metabolismo
4.
Recent Pat Antiinfect Drug Discov ; 8(3): 161-97, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24215506

RESUMEN

The relentless rise in antibiotic resistance among pathogenic bacteria and fungi, coupled with the high susceptibility of burn wounds to infection, and the difficulty of systemically administered antibiotics to reach damaged tissue, taken together have made the development of novel topical antimicrobials for burn infections a fertile area of innovation for researchers and companies. We previously covered the existing patent literature in this area in 2010, but the notable progress made since then, has highlighted the need for an update to bring the reader up to date on recent developments. New patents in the areas of topically applied antibiotics and agents that can potentiate the action of existing antibiotics may extend their useful lifetime. Developments have also been made in biofilm-disrupting agents. Antimicrobial peptides are nature's way for many life forms to defend themselves against attack by pathogens. Silver has long been known to be a highly active antimicrobial but new inorganic metal derivatives based on bismuth, copper and gallium have emerged. Halogens such as chlorine and iodine can be delivered by novel technologies. A variety of topically applied antimicrobials include chitosan preparations, usnic acid, ceragenins and XF porphyrins. Natural product derived antimicrobials such as tannins and essential oils have also been studied. Novel techniques to deliver reactive oxygen species and nitric oxide in situ have been developed. Light-mediated techniques include photodynamic therapy, ultraviolet irradiation, blue light, low-level laser therapy and titania photocatalysis. Passive immunotherapy employs antibodies against pathogens and their virulence factors. Finally an interesting new area uses therapeutic microorganisms such as phages, probiotic bacteria and protozoa to combat infections.


Asunto(s)
Antiinfecciosos Locales/uso terapéutico , Bacteriófagos , Biopelículas , Quemaduras/complicaciones , Inmunización Pasiva/métodos , Patentes como Asunto , Fototerapia/métodos , Probióticos/uso terapéutico , Infección de Heridas/terapia , Humanos , Infección de Heridas/complicaciones
5.
Semin Cutan Med Surg ; 32(1): 41-52, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24049929

RESUMEN

Low-level laser (light) therapy (LLLT) is a fast-growing technology used to treat a multitude of conditions that require stimulation of healing, relief of pain and inflammation, and restoration of function. Although skin is naturally exposed to light more than any other organ, it still responds well to red and near-infrared wavelengths. The photons are absorbed by mitochondrial chromophores in skin cells. Consequently, electron transport, adenosine triphosphate nitric oxide release, blood flow, reactive oxygen species increase, and diverse signaling pathways are activated. Stem cells can be activated, allowing increased tissue repair and healing. In dermatology, LLLT has beneficial effects on wrinkles, acne scars, hypertrophic scars, and healing of burns. LLLT can reduce UV damage both as a treatment and as a prophylactic measure. In pigmentary disorders such as vitiligo, LLLT can increase pigmentation by stimulating melanocyte proliferation and reduce depigmentation by inhibiting autoimmunity. Inflammatory diseases such as psoriasis and acne can also be managed. The noninvasive nature and almost complete absence of side effects encourage further testing in dermatology.


Asunto(s)
Cicatriz/radioterapia , Terapia por Luz de Baja Intensidad/métodos , Rejuvenecimiento , Piel/efectos de la radiación , Cicatrización de Heridas/efectos de la radiación , Humanos
6.
Free Radic Biol Med ; 65: 800-810, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23969112

RESUMEN

Antimicrobial photodynamic therapy (PDT) is used for the eradication of pathogenic microbial cells and involves the light excitation of dyes in the presence of O2, yielding reactive oxygen species including the hydroxyl radical (OH) and singlet oxygen ((1)O2). In order to chemically enhance PDT by the formation of longer-lived radical species, we asked whether thiocyanate (SCN(-)) could potentiate the methylene blue (MB) and light-mediated killing of the gram-positive Staphylococcus aureus and the gram-negative Escherichia coli. SCN(-) enhanced PDT (10 µM MB, 5 J/cm(2) 660 nm hv) killing in a concentration-dependent manner of S. aureus by 2.5 log10 to a maximum of 4.2 log10 at 10mM (P<0.001) and increased killing of E. coli by 3.6 log10 to a maximum of 5.0 log10 at 10mM (P<0.01). We determined that SCN(-) rapidly depleted O2 from an irradiated MB system, reacting exclusively with (1)O2, without quenching the MB excited triplet state. SCN(-) reacted with (1)O2, producing a sulfur trioxide radical anion (a sulfur-centered radical demonstrated by EPR spin trapping). We found that MB-PDT of SCN(-) in solution produced both sulfite and cyanide anions, and that addition of each of these salts separately enhanced MB-PDT killing of bacteria. We were unable to detect EPR signals of OH, which, together with kinetic data, strongly suggests that MB, known to produce OH and (1)O2, may, under the conditions used, preferentially form (1)O2.


Asunto(s)
Antibacterianos/farmacología , Azul de Metileno/farmacología , Óxidos de Azufre/química , Tiocianatos/farmacología , Antibacterianos/química , Escherichia coli/efectos de los fármacos , Azul de Metileno/química , Pruebas de Sensibilidad Microbiana , Oxidación-Reducción , Fotoquimioterapia , Oxígeno Singlete/química , Staphylococcus aureus/efectos de los fármacos , Tiocianatos/química
7.
FEMS Microbiol Rev ; 37(6): 955-89, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23802986

RESUMEN

Reactive oxygen species (ROS) can attack a diverse range of targets to exert antimicrobial activity, which accounts for their versatility in mediating host defense against a broad range of pathogens. Most ROS are formed by the partial reduction in molecular oxygen. Four major ROS are recognized comprising superoxide (O2•-), hydrogen peroxide (H2O2), hydroxyl radical (•OH), and singlet oxygen ((1)O2), but they display very different kinetics and levels of activity. The effects of O2•- and H2O2 are less acute than those of •OH and (1)O2, because the former are much less reactive and can be detoxified by endogenous antioxidants (both enzymatic and nonenzymatic) that are induced by oxidative stress. In contrast, no enzyme can detoxify •OH or (1)O2, making them extremely toxic and acutely lethal. The present review will highlight the various methods of ROS formation and their mechanism of action. Antioxidant defenses against ROS in microbial cells and the use of ROS by antimicrobial host defense systems are covered. Antimicrobial approaches primarily utilizing ROS comprise both bactericidal antibiotics and nonpharmacological methods such as photodynamic therapy, titanium dioxide photocatalysis, cold plasma, and medicinal honey. A brief final section covers reactive nitrogen species and related therapeutics, such as acidified nitrite and nitric oxide-releasing nanoparticles.


Asunto(s)
Antibacterianos , Bacterias , Miel , Infecciones/terapia , Neoplasias/terapia , Especies Reactivas de Oxígeno , Animales , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Antioxidantes/metabolismo , Antioxidantes/farmacología , Bacterias/efectos de los fármacos , Bacterias/metabolismo , Catálisis , Miel/análisis , Humanos , Oxigenoterapia Hiperbárica , Estrés Oxidativo , Fotoquimioterapia , Gases em Plasma , Especies de Nitrógeno Reactivo/metabolismo , Especies de Nitrógeno Reactivo/uso terapéutico , Especies Reactivas de Oxígeno/química , Especies Reactivas de Oxígeno/metabolismo , Especies Reactivas de Oxígeno/uso terapéutico
8.
Biotechnol Adv ; 31(5): 607-31, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22951919

RESUMEN

Phototherapy can be used in two completely different but complementary therapeutic applications. While low level laser (or light) therapy (LLLT) uses red or near-infrared light alone to reduce inflammation, pain and stimulate tissue repair and regeneration, photodynamic therapy (PDT) uses the combination of light plus non-toxic dyes (called photosensitizers) to produce reactive oxygen species that can kill infectious microorganisms and cancer cells or destroy unwanted tissue (neo-vascularization in the choroid, atherosclerotic plaques in the arteries). The recent development of nanotechnology applied to medicine (nanomedicine) has opened a new front of advancement in the field of phototherapy and has provided hope for the development of nanoscale drug delivery platforms for effective killing of pathological cells and to promote repair and regeneration. Despite the well-known beneficial effects of phototherapy and nanomaterials in producing the killing of unwanted cells and promoting repair and regeneration, there are few reports that combine all three elements i.e. phototherapy, nanotechnology and, tissue repair and regeneration. However, these areas in all possible binary combinations have been addressed by many workers. The present review aims at highlighting the combined multi-model applications of phototherapy, nanotechnology and, reparative and regeneration medicine and outlines current strategies, future applications and limitations of nanoscale-assisted phototherapy for the management of cancers, microbial infections and other diseases, and to promote tissue repair and regeneration.


Asunto(s)
Nanomedicina/métodos , Fototerapia/métodos , Medicina Regenerativa/métodos , Animales , Humanos , Fotoquimioterapia/métodos , Regeneración/fisiología
9.
J Biophotonics ; 5(11-12): 827-37, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22807422

RESUMEN

We review the use of transcranial low-level laser (light) therapy (LLLT) as a possible treatment for traumatic-brain injury (TBI). The basic mechanisms of LLLT at the cellular and molecular level and its effects on the brain are outlined. Many interacting processes may contribute to the beneficial effects in TBI including neuroprotection, reduction of inflammation and stimulation of neurogenesis. Animal studies and clinical trials of transcranial-LLLT for ischemic stroke are summarized. Several laboratories have shown that LLLT is effective in increasing neurological performance and memory and learning in mouse models of TBI. There have been case report papers that show beneficial effects of transcranial-LLLT in a total of three patients with chronic TBI. Our laboratory has conducted three studies on LLLT and TBI in mice. One looked at pulsed-vs-continuous wave laser-irradiation and found 10 Hz to be superior. The second looked at four different laser-wavelengths (660, 730, 810, and 980 nm); only 660 and 810 nm were effective. The last looked at different treatment repetition regimens (1, 3 and 14-daily laser-treatments).


Asunto(s)
Lesiones Encefálicas/radioterapia , Terapia por Luz de Baja Intensidad/métodos , Cráneo , Animales , Humanos , Accidente Cerebrovascular/radioterapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA